Month: May 2017

Notizia

Notizia

Roche, Boehringer tout new idiopathic pulmonary fibrosis analyses to boost their rival medications The idiopathic pulmonary fibrosis (IPF)...

Read More

Vitiligo – High Unmet Need Indeed!

Articles

Vitiligo is a common acquired, idiopathic depigmentation disorder which affects at least 1% to 2% of the population irrespective of sex,...

Read More

The Business Cocktail

The Business Cocktail

Merck’s Remicade discounting put squeeze on biosims—and broke U.K. law, officials say Under biosimilar assault in Europe, Merck...

Read More

The Snippet: FDA grants accelerated approval to pembrolizumab

Snippets

The U.S. Food and Drug Administration granted accelerated approval to pembrolizumab (KEYTRUDA, Merck & Co.) for adult and pediatric...

Read More

Notizia

Articles

Read More

The Business Cocktail

The Business Cocktail

Key Humira patent goes down via IPR—but biosims makers shouldn’t celebrate yet One of AbbVie’s Humira patents bit the dust late...

Read More

The Snippet: Geneticists enlist engineered virus and CRISPR to battle citrus disease

Snippets

Fruit farmers in the United States have long feared the arrival of harmful citrus tristeza virus to their fields. But now, this devastating...

Read More

Notizia

Notizia

Read More
Close